Open Access

[Corrigendum] Ceramide synthase‑4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor‑κB signaling pathway

  • Authors:
    • Jinwu Chen
    • Xiaojie Li
    • Dengjiao Ma
    • Tao Liu
    • Pingping Tian
    • Chuanfang Wu
  • View Affiliations

  • Published online on: February 15, 2021     https://doi.org/10.3892/ol.2021.12551
  • Article Number: 290
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

April-2021
Volume 21 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen J, Li X, Ma D, Liu T, Tian P and Wu C: [Corrigendum] Ceramide synthase‑4 orchestrates the cell proliferation and tumor growth of liver cancer <em>in vitro</em> and <em>in vivo</em> through the nuclear factor‑κB signaling pathway. Oncol Lett 21: 290, 2021
APA
Chen, J., Li, X., Ma, D., Liu, T., Tian, P., & Wu, C. (2021). [Corrigendum] Ceramide synthase‑4 orchestrates the cell proliferation and tumor growth of liver cancer <em>in vitro</em> and <em>in vivo</em> through the nuclear factor‑κB signaling pathway. Oncology Letters, 21, 290. https://doi.org/10.3892/ol.2021.12551
MLA
Chen, J., Li, X., Ma, D., Liu, T., Tian, P., Wu, C."[Corrigendum] Ceramide synthase‑4 orchestrates the cell proliferation and tumor growth of liver cancer <em>in vitro</em> and <em>in vivo</em> through the nuclear factor‑κB signaling pathway". Oncology Letters 21.4 (2021): 290.
Chicago
Chen, J., Li, X., Ma, D., Liu, T., Tian, P., Wu, C."[Corrigendum] Ceramide synthase‑4 orchestrates the cell proliferation and tumor growth of liver cancer <em>in vitro</em> and <em>in vivo</em> through the nuclear factor‑κB signaling pathway". Oncology Letters 21, no. 4 (2021): 290. https://doi.org/10.3892/ol.2021.12551